InsidersTradesSigma
Follow the 인투셀 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 인투셀 has logged 12 public disclosures. The latest transaction was disclosed on 2 February 2026 (Purchase). Among the most active insiders: 서영석. All data is free.
12
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 February 2026
Declarations12 total
861,587 sharesKRXDART:20250529000443
12 of 12 declarations
Acerca de 인투셀
인투셀 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades.